Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USA.
Nature. 2011 May 19;473(7347):317-25. doi: 10.1038/nature10146.
Atherosclerosis is a chronic disease of the arterial wall, and a leading cause of death and loss of productive life years worldwide. Research into the disease has led to many compelling hypotheses about the pathophysiology of atherosclerotic lesion formation and of complications such as myocardial infarction and stroke. Yet, despite these advances, we still lack definitive evidence to show that processes such as lipoprotein oxidation, inflammation and immunity have a crucial involvement in human atherosclerosis. Experimental atherosclerosis in animals furnishes an important research tool, but extrapolation to humans requires care. Understanding how to combine experimental and clinical science will provide further insight into atherosclerosis and could lead to new clinical applications.
动脉粥样硬化是一种动脉壁的慢性疾病,也是全球范围内导致死亡和丧失生产性生命年的主要原因。对该疾病的研究提出了许多关于动脉粥样硬化病变形成以及心肌梗死和中风等并发症的病理生理学的引人注目的假说。然而,尽管取得了这些进展,我们仍然缺乏确凿的证据表明脂蛋白氧化、炎症和免疫等过程在人类动脉粥样硬化中具有关键作用。动物实验性动脉粥样硬化提供了一个重要的研究工具,但需要谨慎外推到人类。了解如何结合实验科学和临床科学将为动脉粥样硬化提供进一步的深入了解,并可能导致新的临床应用。